KFY - Hot Stocks: TWTR rises on latest Musk headlines; GKOS clinical data; GTLB climbs on earnings; KFY falls

Twitter ( TWTR ) saw its stock advance in Wednesday's intraday action, bolstered by some seemingly positive developments in its ongoing legal case against Elon Musk.

Meanwhile, Glaukos ( GKOS ) also showed intraday strength, soaring on the release of positive clinical trial data. GitLab ( GTLB ) was another notable gainer, thanks to Street-topping quarterly results.

Looking to the downside, Korn/Ferry ( NYSE: KFY ) suffered a setback, with the release of earnings news sparking a double-digit percentage decline.

Gainers

Twitter ( TWTR ) gained ground in intraday trading, boosted by the latest headlines in its legal wrangling with would-be buyer Elon Musk. Shares rose 5% after a judge denied an attempt by Musk to delay a trial related to his attempt to break a takeover deal with the social media giant.

The advance followed a tick higher on Tuesday, when the judge in the case criticized Musk's attorneys about some document discovery in a hearing related to the discontinued $44B takeover.

Elsewhere, shares of Glaukos ( GKOS ) jumped almost 25% in intraday action following the release of favorable clinical trial data . The company revealed that its iDose TR eye implant reached the primary endpoints in two clinical trials in patients with open-angle glaucoma or ocular hypertension.

In other news, GitLab ( GTLB ) climbed 7% in midday trading after beating expectations with its latest financial figures . The software development platform's loss came in narrower than analysts had projected, with revenue that jumped 74% from last year.

Decliner

Korn/Ferry ( KFY ) lost ground in the wake of its quarterly results . Shares dropped 10% amid a weak bottom line and a shaky outlook.

While the management consulting firm reported a 19% improvement in revenue, its profit figure failed to meet analysts' expectations. Meanwhile, for fiscal 2023, the company predicted earnings between $1.34 and $1.50 per share. This compares to analysts' consensus of $1.50 per share.

To keep up with Wall Street's best- and worst-performing stocks, click over to Seeking Alpha's On The Move section .

For further details see: